Rwanda
CSM GlobalPharma will break ground on a $65 million pharmaceutical manufacturing plant in Rwanda in mid-2011. The facility will support production of solids, liquids, biological vaccines and injectables, and therapeutics with active pharmaceutical Ingredients (APIs). The plant is expected to become operational two years after the start of construction. CSM GlobalPharma is a partnership of Candila Pharmaceuticals of India and U.S.-based Holtzman Group.
